Back to catalogue
№ 092 27 filings · 2021-05-26 → 2026-06-12

C&C GROUP PLC

CCR
Food, Beverage and Tobacco Share price 95.70p Market cap £353m Overall fit 215 /1000

Pure consumer-staples drinks business with zero AI value-chain exposure, mixed operating leverage (high in Branded, near-zero in distribution), and a mildly undervalued share price offset by deteriorating earnings trend and governance concerns. Misaligned with the investor's three pillars.

Fair value range 105p–150p Mid case · £471m
Absolute upside +33.6% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clean segmental disclosure separates resilient Branded (16.5% margin) from low-margin MCB
  • Strong liquidity (€326m) and facilities to 2030 give time for recovery
  • Cumulative €105m returned to shareholders since FY25; €150m programme on track
Limits the call
  • Through-cycle earnings hard to anchor given €30-40m+ annual exceptional items
  • Strategy in flux until September 2026 Capital Markets Day
Methodology

EV/EBITDA multiple (5.5-7.5x) cross-checked vs adjusted P/E

In one line · bull case

Self-help margin recovery in MCB plus a resilient high-margin Branded core could rerate the stock 30-50% from the current depressed level, with quality balance sheet providing downside support.

In one line · biggest risk

MCB margin recovery proves slower than guided as hospitality demand stays weak and category mix continues shifting against the wholesale business, leaving the recovery story to slip again into FY28.

Drivers
AI beneficiary 5 /100
Zero AI exposure — consumer-staples drinks producer and wholesaler with no AI value-chain role.
Operating leverage 35 /100
High in Branded (~16% margin, fixed-cost breweries with spare capacity) but ~80% of revenue is low-margin pass-through distribution.
Earnings vs expectations 25 /100
Jan 2026 profit warning followed in-line October interims; pattern of H2 disappointment after H1 reassurance.
Growth momentum 22 /100
Revenue -5.7% in FY26, FY27 guided flat with profit dilution risk — clearly decelerating.
Moat 42 /100
Tennent's #1 in Scotland and Bulmers #1 in Ireland are durable regional brands, but limited geographic depth and no moat in MCB distribution.
Earnings quality 32 /100
€40m+ recurring exceptional items per year, FY24 restatement and control rebuild ongoing — reported numbers overstate underlying.
Management quality 33 /100
Two CEO and two CFO changes since FY24, strategy reversed in May 2026, profit warning three months after reassuring interims.
Cyclicality 50 /100
Hospitality-exposed consumer staples — defensive vs autos/banks but more cyclical than utility-grade staples.
Leverage 48 /100
Net debt 1.6x EBITDA (rising from 0.9x), facilities to 2030, manageable but trending wrong way.
Value-trap signals · 6
  • Declining revenue (-5.7% FY26) with FY27 guided flat-to-down
  • Repeated profit warnings and guidance cuts
  • €30-40m+ annual exceptional items obscuring underlying earnings
  • Strategy reversal (abandoned 'One C&C' May 2026) ahead of new plan in Sep 2026
  • UK cider category in structural decline (brand impairment €15.6m FY26)
  • Hospitality channel pressure from cost inflation and shorter trading hours

C&C Group plc (CCR) — Investment Research Note

Executive summary

C&C Group is a vertically-integrated drinks business spanning brand ownership (Bulmers Irish cider, Tennent's Scottish lager, Magners, premium portfolio) and the UK/Ireland's leading hospitality drinks wholesaler (Matthew Clark Bibendum, "MCB"). The trajectory across the period is one of stalled execution: revenue declined from €1,652m (FY24) → €1,665m (FY25) → €1,570m (FY26), operating profit re-based from €60m (FY24) → €77m (FY25) → €70m (FY26), and the group has been through CEO change, CFO change, an accounting-controls restatement (FY24) and a January 2026 profit warning 2026-05 FY results; 2026-01 trading update. The single most important point for valuation is that despite a 43% one-year share-price decline, FY27 guidance is for profits "similar to the current year" with explicit warning of "short-term profit dilution" — the bull case requires conviction in the FY28+ recovery promised at September 2026 Capital Markets Day 2026-05 FY results.

Fair value estimate

Methodology: EV/EBITDA multiple, cross-checked with adjusted P/E. The business is too cash-generative for DCF to be heroic and too multi-segment for a clean SOTP without management guidance.

Key inputs (FY26):

  • Adjusted EBITDA: €104.3m (~£88m at €1:£0.85)
  • Operating profit pre-exceptional: €70.5m (~£60m)
  • Net debt ex-leases: €121.4m (~£103m); leverage 1.6x
  • Adjusted basic EPS: 10.2c (~8.7p)
  • Shares outstanding: 368.3m

Applying 5.5–7.5x EV/EBITDA (discount to staples sector ~9–11x for execution risk, distribution drag, and a thin-margin wholesale business that doesn't deserve a staples multiple):

  • Low: 5.5x €104m = €574m EV − €121m debt = €453m equity ≈ £384m / 104p
  • High: 7.5x €104m = €782m EV − €121m debt = €661m equity ≈ £561m / 152p
  • Mid: 6.5x ≈ £473m mcap / ~128p per share

Cross-check on adjusted EPS: 10.2c ≈ 8.7p. At 13–15x (acceptable for a mediocre staple with a recovery story), 113p–131p — consistent.

Fair value range: 105p – 150p (mid ~128p) Implied mcap range: £386m – £553m (mid ~£471m) Current mcap: £348.1m → upside to mid ~+34%; range -1% to +57%

Sector context

Consumer Staples / Food, Beverage and Tobacco — confirmed. C&C sits below typical peers in quality (lower margins, weaker brand portfolio than Diageo/Britvic, dilutive wholesale arm), and in line on leverage (1.6x EBITDA, comparable to mid-cap drinks). Growth is below sector. Listed peers worth comparing: Britvic (until takeout), AG Barr (Irn-Bru, superior margins), Marston's (hospitality-adjacent), and on the wholesale side a partial analogue is Conviviality (gone) or Bargain Booze/Rontec privates.

Investment thesis (3 bullets)

  • Self-help margin recovery in MCB is the obvious lever: Distribution operating margin halved to 1.5% in FY26 from 2.3%, dragged by category mix (wine/spirits → beer/cider). New strategic framework (May 2026) separates MCB into its own operating model focused on margin rebuild, with explicit cost actions including a ~4% headcount reduction already in flight 2026-05 FY results. Even a return to 2.5% margins on £1.26bn revenue would add ~€13m to operating profit (~20% uplift).
  • Brand business is the quality core: Branded segment grew operating profit 11% to €51m in FY26 with margin expanding 110bps to 16.5%, Tennent's growing share in Scotland and Bulmers gaining 1.4ppts in Ireland On-Trade. The Magners GB re-take from BBG and the Innis & Gunn brand acquisition (Mar 2026, £4.5m) extend optionality with negligible execution cost 2026-05 FY results; 2026-03 acquisition announcement.
  • Capital returns continue and balance sheet is sound: €105m cumulative returned since FY25 start via dividends + buybacks, against a stated €150m three-year target; facilities extend to 2030 and a planned €1bn share-premium-to-retained-earnings reorganisation will unlock distributable reserves 2026-05 FY results; 2025-10 interim.

Key risks (3 bullets)

  • MCB margin recovery may be slower than guided: FY26 distribution profit fell 37% to €19.5m, and FY27 is already flagged for "short-term profit dilution" from planned volume exits ahead of cost takeout 2026-01 trading update. Hospitality demand remains weak per the May 2026 commentary; consumer down-trading from wine/spirits to beer is structural, not cyclical.
  • Earnings quality / exceptional-item cadence: €40.7m exceptional charges in FY26 (€36.3m FY25, €150m FY24) including brand impairments (€15.6m FY26), restructuring (€23.4m), risk/control review costs, and ongoing onerous-apple-contract provisions. The pattern of large recurring "one-offs" suggests the €70m underlying figure overstates true earnings power 2026-05 FY results; 2025-05 FY25 results.
  • Governance and execution track record: FY24 saw an accounting-restatement that deferred the annual report; the CEO changed in early 2025 (Findlay→White), the CFO changed in early 2026 (Andrea→Phillips), the "One C&C" strategy was explicitly abandoned in May 2026, and the January 2026 profit warning was driven by issues management had described in October 2025 as "controlled" 2024-10 interim; 2026-01 trading update; 2026-05 FY results.

Operating leverage

The group has bifurcated operating leverage. The Branded segment is the high-fixed-cost half: two large owned breweries (Wellpark Glasgow, Clonmel Tipperary) with management explicitly stating that they "retain spare capacity to respond rapidly to volume opportunities" 2026-05 FY results. Branded operating margin moved 15.4%→16.5% on just 4% net revenue growth in FY26, implying ~25%+ incremental contribution margin on volume gains. By contrast, MCB is a low-margin distribution business with ~1.5–2.3% operating margin and very little structural fixed-cost leverage — incremental case volumes are a pass-through. The mix matters: a 10–20% upside surprise in Branded revenue would plausibly add €15–25m to operating profit (>30–50% uplift on FY26's €70m), but a 10–20% surprise in MCB volumes only adds €2–6m. There are no obvious capacity-constrained inflection points beyond breweries running below nameplate. For this investor's "long-tail upside" preference, the leverage is moderate at best — high in 16% of revenue, weak in the other 80%.

Value-trap signals

  • Declining revenue trend: €1,665m → €1,570m (-5.7%) in FY26, with FY27 guided flat-to-down. UK cider market in structural decline (Cider brands impaired €15.6m FY26).
  • Repeated guidance misses: January 2026 profit warning materially below initial FY26 expectations; "year of evolution" / refresh language has repeated through three CEO/Chair transitions.
  • Heavy serial exceptional items masking weaker underlying earnings (€40m+ p.a. for several years).
  • Strategic flip-flops: "One C&C" abandoned May 2026 in favour of two-operating-model structure that will be detailed in September 2026 — investors are being asked to wait for the plan that explains the plan.
  • Hospitality category exposure: pubs/restaurants under structural pressure from cost inflation and shorter operating hours.

Earnings vs. expectations

  • FY24 (Feb 2024): Severe ERP-implementation disruption in MCB and accounting restatement — material miss.
  • FY25 (Feb 2025): Op profit €77m vs. management's medium-term €100m target — beat the depressed FY24 base but well below the longer-stated ambition.
  • H1 FY26 (Aug 2025): In line — operating profit €41.9m vs. guidance range €41.5–42.0m given a month earlier 2025-09 trading update; 2025-10 interim.
  • Full year FY26: Miss — Jan 2026 trading update cut full-year operating profit guidance to €70–73m (delivered €70.5m), against the H1 view that "full-year earnings expectations maintained" just three months earlier 2026-01 trading update; 2025-10 interim. The pattern is more misses than beats over the period, with management commentary in H1 routinely undermined by H2 trading. Analyst consensus is not explicitly cited in filings, but the share-price reaction (-43% one-year) indicates persistent disappointment.

Conviction

Conviction: 3 (moderate) — I am moderately confident the stock is undervalued on a multi-year view at 95p, but the conviction has real limits.

Anchors (support the valuation call):

  • Clean dual-segment disclosure with margins, volumes and capital-allocation reasonably transparent.
  • Branded segment alone (€51m operating profit) on a 10–12x multiple covers a meaningful portion of current EV.
  • Strong liquidity (€326m) and committed facilities to 2030 give the recovery time to play out.

Limits (constrain confidence):

  • The genuine through-cycle earnings number is hard to anchor when exceptional items run €30–40m+ per year.
  • Strategic direction is in flux until at least the September 2026 Capital Markets Day.

Driver discussion

ai_beneficiary (5): A pure consumer-staples drinks business. Zero mentions of AI in any of the filings reviewed. The investor's primary preference for AI value-chain exposure is not satisfied.

operating_leverage (35): High in Branded (16.5% margin, fixed-cost breweries with spare capacity), but the dominant ~80% revenue mix is low-margin distribution where incremental revenue carries near-zero incremental margin. Blended OL is below average for the staples sector.

Overall score (210): Fails on AI exposure (~35% of weighting → ~0/35), partial credit on valuation (~25% → ~15/25 since shares look mildly undervalued but trends are deteriorating), weak on operating leverage (~25% → ~9/25), and acceptable but not strong on quality (~15% → ~8/15). Total ~32/100 → ~320 raw, scaled down for the complete absence of an AI thesis to ~210.

Filings consulted · 27

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-06-12Annual Report And Notice OF Agm2026-06-12_9616086_annual-report-and-notice-of-agm.md0.95
  2. 2026-05-19Final Results2026-05-19_9574215_final-results.md1.00
  3. 2026-03-06Acquisition OF Innis Amp Gunn Brand2026-03-06_9462992_acquisition-of-innis-amp-gunn-brand.md0.75
  4. 2026-01-23Fy26 Trading Update2026-01-23_9378314_fy26-trading-update.md0.85
  5. 2025-10-28Interim Results2025-10-28_9197743_interim-results.md0.77
  6. 2025-09-18Fy2026 First Half Trading Update2025-09-18_9115206_fy2026-first-half-trading-update.md0.72
  7. 2025-07-14Result OF Agm2025-07-14_8976597_result-of-agm.md0.26
  8. 2025-06-16Annual Report And Notice OF Agm2025-06-16_8931638_annual-report-and-notice-of-agm.md0.81
  9. 2025-05-28Final Results2025-05-28_8899222_final-results.md0.65
  10. 2025-03-13Trading Update2025-03-13_8776685_trading-update.md0.55
  11. 2025-02-25Notice OF Pre Close Trading Update2025-02-25_8750464_notice-of-pre-close-trading-update.md0.55
  12. 2024-10-29Interim Results2024-10-29_8514423_interim-results.md0.58
  13. 2024-09-09Fy2025 First Half Trading Update2024-09-09_8405293_fy2025-first-half-trading-update.md0.55
  14. 2024-08-15Result OF Agm2024-08-15_8369623_result-of-agm.md0.20
  15. 2024-08-15Agm Trading Update And Directorate Change2024-08-15_8367556_agm-trading-update-and-directorate-change.md0.55
  16. 2024-07-31Response TO Shareholder Letter2024-07-31_8341385_response-to-shareholder-letter.md0.55
  17. 2024-07-17Notice OF Agm2024-07-17_8316877_notice-of-agm.md0.20
  18. 2024-06-24Response TO Shareholder Letter2024-06-24_8275055_response-to-shareholder-letter.md0.55
  19. 2024-05-10Timing OF Fy2024 Full Year Results2024-05-10_8187308_timing-of-fy2024-full-year-results.md0.45
  20. 2023-07-13Result OF Agm2023-07-13_7631157_result-of-agm.md0.14
  21. 2023-06-14Annual Report Amp Notice OF Agm2023-06-14_7574365_annual-report-amp-notice-of-agm.md0.24
  22. 2022-07-07Result OF Agm2022-07-07_6920664_result-of-agm.md0.07
  23. 2022-06-08Annual Report And Notice OF Agm2022-06-08_6868774_annual-report-and-notice-of-agm.md0.24
  24. 2021-07-01Result OF Agm2021-07-01_6504216_result-of-agm.md0.07
  25. 2021-06-21Results OF Rump Placing2021-06-21_6733304_results-of-rump-placing.md0.17
  26. 2021-06-21Results OF Rights Issue2021-06-21_6732465_results-of-rights-issue.md0.17
  27. 2021-05-26Annual Report Amp Notice OF Agm2021-05-26_6514847_annual-report-amp-notice-of-agm.md0.10

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-05-26 and 2026-06-12. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.